CSIMarket
 


Stock Market
NYSE_By_Kjetil_Ree__[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]

Market Surges as Internet Services and Social Media Stocks Drive Growth

Stock Market Trading


In today's dynamic stock market, Monday, March 18, 2024, the market experienced a surge driven by the Internet Services and Social Media industry, specifically led by Alphabet Inc.
(GOOGL) and Alphabet Inc.
Economy
Rain-Idea-Concept-Sure-Dollar-Economy-Umbrella-2904775 Gross Domestic Product

In the fourth-quarter GDP grew 3.2 %

The U.S. economy grew at a solid pace during the October-through-December period, led by growth in investments, exports and government spending.


factory_night_long_exposure_industry_power_industrial_energy_global-589754 Industrial production

Drop in car production led total industrial output down



turn-on-2932999__340 Producer Price Index

Inflation higher in February 2024

Prices increased on the faster pace again, led by growth in food, materials for manufacturing and crude petroleum prices.

conversation_By_Dgurteen__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Equitable Financial Life Insurance Company

Equitable Financial Life Insurance Company Defies Market Volatility With Impressive Performance in Q4 2023

The stock market is a volatile and ever-changing place that often leaves investors on the edge of their seats. However, amidst all the ups and downs, there are always companies that manage to stand out and prove their worth. One such company is Equitable Financial Life Insurance Company.
In its most recent fiscal period, Equitable Financial Life Insurance Company reached a zero gain at $0.00 per share, opposite of $0.00 per share a year prior. While this may not seem like a significant change, it is important to note that the company had previously realized a gain of $2.00 billion. This shift in performance highlights the resilience and adaptability of Equitable Financial Life Insurance Company.

architecture-2256489_960_720.jpg Hawthorn Bancshares Inc

Hawthorn Bancshares, Inc. Slips into Deficit Due to Decrease in Business in Most Recent Fiscal Period

Hawthorn Bancshares, Inc. has recently announced a quarterly cash dividend of $0.17 per common share, a move that has been welcomed by its shareholders. The decision to declare a cash dividend reflects the company's dedication to providing strong returns for its investors. This announcement comes on the heels of the company's recent financial success, despite reporting a fourth-quarter net loss of $7.4 million.
The lower orders the company faced led to dwindling revenue and a greater loss for the most recent fiscal period, with earnings per diluted share dropping to $(1.05). Despite this setback, Hawthorn Bancshares, Inc. remains optimistic about its future prospects and is taking steps to ensure shareholder gain through initiatives such as the quarterly cash dividend.
In terms of market and stock performance, Hawthorn Bancshares, Inc. witnessed a decrease of -7.12% in its shares during March 2024, bringing the year-to-date performance to -24.06%. The company's shares are currently trading 29% above its 52-week low, indicating some volatility in the market. However, the company remains focused on driving growth and delivering value to its shareholders in the long term.

Cis_di_nola_By_Alcott1953_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Management Changes

Teri List Joins Lululemon Board of Directors, Bringing Vast Business Experience to Fuel Global Growth

Published Tue, Mar 19 2024 10:30 AM UTC



Lululemon Athletica Inc (NASDAQ: LULU) has recently announced the appointment of Teri List to its prestigious Board of Directors. Bringing a wealth of business leadership experience and a successful track record as a board member for large international companies, Teri is expected to add significant value to Lululemon as it continues to expand globally. With her in...

    Recently Published News
Ambase Corporation

Spending Spree: Ambase Corporation's Expenditures Surge in Q4 2023

Financial Report: Ambase Corporation Faces Revenue Shortfalls in Q4 2023
March 19, 2024
AmBase Corporation (OTC: ABCP) recently announced a net loss of $5,271,000 or $0.13 per share for the twelve months ended December 31, 2023. This comes as the stockholders did not anticipate any adjustments to the revenue during the earnings cycle of fiscal October to December 2023.
Investors are particularly concerned about ABCP's operating deficit, which stood at $-1.291 million during the same period. They are eagerly awaiting the development of new revenue sources in the coming period. While they are less worried about the company's organizational and operational excellence in the Professional Services sector, they understand that businesses often go through rough patches in pursuit of prosperous revenue sources.

Frequency Electronics Inc

FEI Shines Amidst Financial Challenges with Impressive Revenue Surge

Investors in Frequency Electronics Inc (FEI) may have been disappointed by the company's recent financial results, which showed a balanced bottom line despite a significant surge in revenue. However, a closer look at the numbers reveals a story of growth, resilience, and potential for future success.
The fact that FEI was able to achieve balanced books at $0.00 per share in the most recent fiscal period is a testament to the company's ability to manage costs and navigate challenges in the marketplace. Despite this achievement, the real standout figure is the 29.134% increase in revenue to $13.71 million, showcasing strong demand for FEI's products and services.

Product Service News

BOCA RATON, Fla. - Terran Orbitals, a prominent European nano and microsatellite manufacturer, has successfully handed over the Hera Milani satellite to the European Space Agency (ESA) in a formal ceremony held at Tyvak International's premises in Torino, Italy, on March 14th. This significant achievement marks another milestone in the space industry's pursuit of scientific exploration and techn...

Published Tue, Mar 19 2024 10:30 AM UTC

Terran Orbitals Delivers Milani Satellite to European Space Agency for Hera MissionBOCA RATON, Fla. - Terran Orbitals, a prominent European nano and microsatellite manufacturer, has successfully handed over the Hera Milani satellite to the European Space Agency (ESA) in a formal ceremony held at Tyvak International's premises in Torino, Italy, on March 14th. This significant...

8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Walkme Ltd

WalkMe Ltd Surpasses Expectations with Positive Growth Despite Q4 Loss

WalkMe Ltd, a leading provider of digital adoption solutions, announced its fourth-quarter and full-year financial results for 2023. Despite reporting a loss of $-0.67 per share for the quarter, compared to a loss of $-1.09 per share a year ago, the company showcased positive growth. Revenue increased by 8.96% to $266.95 million, compared to $245.01 million in the same period last year.
In the Software & Programming industry, WalkMe Ltd outperformed its contemporaries, with a revenue growth of 8.96% compared to the industry average of 3.32%. This impressive performance is a testament to the company's successful business strategies.

Inside_a_computer_By_nrkbeta_(originally_posted_to_Flickr_as_Maskinvare)__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common Intchains Group Limited

2. Overcoming Challenges: The Resilience of Intchains Group Limited in the Face of Adversity

Intchains Group Limited: Overcoming Adversity and Expanding Horizons
Intchains Group Limited, a pioneer in providing integrated solutions for blockchain applications, recently disclosed its financial results for the three-month period ending December 31, 2023. While the figures may seem alarming at first glance, the company's resilience and determination to succeed shine through, as it continues to make significant strides in the blockchain industry.
The financial report revealed a substantial decline in revenue, which faded by a staggering -83.139% to $11.58 million compared to the corresponding reporting period a year prior. Furthermore, the net deficit per share has extended to $-0.03, a significant increase from the previous reporting period. However, it is crucial to understand that these figures do not define the future of Intchains Group Limited, but rather represent a challenge that the company is ready to overcome.

city-690158_960_720 National Cinemedia Inc

Advertising Company Reports Surprising Boost in Revenue During Fourth Quarter of 2023

National Cinemedia Inc shares have experienced a notable gain of 10.27% over the past five trading days. This increase brings the share price up by 7.07% during the first quarter of 2024. Additionally, the shares of National Cinemedia Inc are currently trading on the NASDAQ at 59.1% above their 52-week average.
These positive developments coincide with the recent announcement of a new $100 million share repurchase program by National Cinemedia Inc. The program, authorized by the Board of Directors, allows for the purchase of the company's common stock until April 1, 2027. This strategic move by the company highlights its confidence in future growth and value, as it invests in itself and returns additional value to shareholders.

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Neurogene Inc

Neurogene Inc. Breaks Ground in Rare Neurological Disorder Research with Expansion of NGN-401 Trial

Neurogene Inc., a leading clinical-stage company specializing in genetic medicines for rare neurological disorders, has recently announced its plans to expand its Phase 1/2 gene therapy clinical trial for NGN-401. This trial is particularly focused on female pediatric patients suffering from Rett syndrome, a debilitating genetic disorder that primarily affects the nervous system. In addition to expanding the trial, Neurogene Inc. also aims to improve the enrollment process to allow for faster participation and assessment.
Rett syndrome, although considered a rare condition, has a profound impact on the lives of patients and their families. It predominantly affects females and is caused by mutations in the MECP2 gene. Symptoms typically appear between six to eighteen months after birth and result in severe impairments in physical, cognitive, and social functioning. Children with Rett syndrome often lose purposeful hand skills, experience regression in language and motor abilities, exhibit repetitive hand movements, and develop respiratory irregularities. Currently, there is no cure for Rett syndrome, and treatment primarily focuses on managing symptoms and providing supportive care.

pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Eyenovia Inc

Eyenovia Inc Faces Challenges as Shares Plummet and Future Prospects Remain Uncertain



Eyenovia Inc, a major pharmaceutical preparations company, has witnessed a significant drop in its shares over the past month. This decline adds to the year-to-date poor performance. Additionally, the company is currently trading on the NASDAQ well below its 52-week average. These developments raise concerns about Eyenovia's future prospects and its ability to overcome these challenges. Furthermore, factors such as a co-promotion agreement and recent financial results also contribute to the uncertainty surrounding the company's future.
1. Co-Promotion Agreement with NovaBay Pharmaceuticals:
Eyenovia's strategic partnership with NovaBay Pharmaceuticals aims to expand market presence and provide a wider range of ophthalmic solutions. Under this agreement, NovaBay will market Eyenovia's Clobetasol propionate ophthalmic suspension, while Eyenovia will promote NovaBay's Avenova Antimicrobial Lid & Lash Solution. This collaboration intends to effectively target eye care professionals across the United States. However, the impact and success of this agreement remain to be seen.

Model2100sm_By_Goldstein_Group__[CC-BY-SA-2.0_(http_creativecommons.org_licenses_by-sa_2.0)]_via_Wikimedia_Common R F Industries Ltd

R F Industries Ltd's Revenue Fades, Stock Price Plummets

R F Industries Ltd, a provider of connectivity solutions for the wireless communications and telecommunications industries, has experienced a significant decline in its stock price over the past year. The company's stock has fallen by 26.95% from a year ago, bringing the share price down by 12.36% in the past 90 days. Currently, the stock is trading only 23.1% above its 52-week low.
The decline in R F Industries Ltd's stock price can be attributed to weak demand, which has led to an increase in losses for the company. For the period of November to January 31, 2024, RFIL reported a shortfall per share of $-0.13, up from $-0.11 in the previous year. Revenue also saw a significant decline, dropping by 27.476% to $13.30 million from $18.34 million the year before. In the fourth quarter alone, revenue fell by 17.229% from $16.07 million, resulting in a growing deficit of $-0.08 per share.

Integrated_circuits_By_T137_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Red Cat Holdings Inc

Red Cat Holdings Inc. Skyrockets with 88.24% Revenue Surge in Q3 of 2024

Red Cat Holdings, Inc., a leading drone technology company, has reported record revenue for the company in the Fiscal Third Quarter of 2024. This marks the third consecutive quarter of double-digit sequential growth for Red Cat. The company's revenue rose strongly by 88.24% to $5.85 million from $3.11 million in the same reporting season a year prior. Sequentially, revenue surged by 48.77% from $3.93 million.
The strong revenue growth is a positive sign for Red Cat Holdings, especially considering that the company exceeded its sector peers on the revenue angle. While the rest of the Software & Programming sector expressed a 3.32% top-line elevation during the same period, Red Cat achieved significant growth, indicating its competitive advantage in the market.

Electronics-Processor-Electricity-Computer-1288717 Avenue Therapeutics Inc

Among many companies, the ATXI reported as well its fourth quarter of 2023 performance

Avenue Therapeutics Inc, a prominent pharmaceutical company, has been making waves in the medical industry with its groundbreaking advancements in the treatment of various neurological disorders. Recently, the company presented its preclinical data on BAER-101 at the American Society for Experimental Neurotherapeutics Annual Meeting, showcasing its full suppression of seizure activity in absence epilepsy. This discovery has the potential to revolutionize anti-seizure drug development and significantly improve the lives of those affected by this condition.
Absence epilepsy is a neurological disorder characterized by intermittent episodes of unconsciousness and staring spells. It predominantly affects children and adolescents, often leading to academic and social challenges. The underlying cause of this condition involves abnormal electrical activity in the brain, resulting in seizures characterized by momentary lapses in consciousness. Prompt and effective treatment is crucial in preventing long-term complications and enhancing the quality of life for individuals with absence epilepsy.

Clean_room_By_E.gordienko_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Product Service News

Coherent Corp. Breaks Barriers in Optical Networking with Revolutionary Wavemaker and Waveshaper Solutions

Published Tue, Mar 19 2024 10:00 AM UTC

Coherent Introduces Wavemaker and Waveshaper Optical Solutions for Multi-Wavelength TransmissionsPITTSBURGH, March 19, 2024 ?? Coherent Corp. (NYSE: COHR), a global leader in optical networking, announced today the introduction of two new optical test instrumentation products. The Wavemaker and Waveshaper solutions are set to revolutionize multi-wavelength transmissions in t...

Product Service News

Confluent Empowers Data Streaming with Tableflow and Simplifies Migration Processes for Businesses.

Published Tue, Mar 19 2024 10:00 AM UTC

Confluent Unveils Tableflow to Unite Analytics and Operations with Data Streaming and Simplify Data Migration ProcessesConfluent, the data streaming pioneer, continues to innovate and expand its offerings with the introduction of Confluent Tableflow and the Confluent Migration Accelerator. These new capabilities aim to make data streaming, connecting, governing, and processi...

Product Service News

s. The company's subsidiary, Roy Anderson Corp, has secured a prestigious contract valued at approximately $80.7 million for the construction of a new residence hall at Mississippi State University. This 155,000 square-foot, five-story building will be a welcome addition to the university campus in Starkville, MS.Tutor Perini Corporation's consistent ability to secure such high-profile p...

Published Tue, Mar 19 2024 10:00 AM UTC

Lunda Construction, a subsidiary of Tutor Perini Corporation, has emerged as the apparent low bidder for a significant infrastructure project, further solidifying its position as a leader in the construction industry. The Illinois Department of Transportation has selected Lunda Construction for a bridge replacement and highway improvement project on I-64, near Grayville, Ill...

Pharmacyte Biotech Inc

The evolving company from the Biotechnology & Pharmaceuticals market the PMCB reported the fiscal third quarter of 2024, numbers

The Biotechnology & Pharmaceuticals industry insiders have begun to analyze the third-quarter earnings of 2024. As of now, the industry insiders have observed an operating loss of $-1.868946 million from a particular company, which has not yet disclosed any revenue for the period from November to January 31, 2024. In order to provide some context for the recent performance, it is worth comparing it to the same period in 2023, when the company reported an operating loss of $-1.552983 million.
One of the notable observations from the third quarter of 2024 earnings season, apart from the absence of revenue, is the significant increase in net deficit. The company recorded a net deficit of $-1.401 million, which is considerably higher than the $-0.764 million reported in the corresponding financial reporting period a year ago.

Clinical Study

Acromegaly is a rare hormonal disorder caused by the excessive production of growth hormone (GH), which leads to the overgrowth of body tissues. Characterized by abnormal growth in certain body parts, such as the hands, feet, and face, acromegaly also results in various metabolic abnormalities and co-morbidities. One of the primary treatment s for acromegaly is to normalize the levels of insulin...

Published Tue, Mar 19 2024 10:00 AM UTC

Crinetics Pharmaceuticals, a clinical-stage biotechnology company focused on developing innovative therapeutics for rare endocrine diseases and endocrine-related tumors, has announced promising results from two separate studies evaluating the efficacy of their once-daily oral drug, paltusotine. In the Phase 3 PATHFNDR-2 study conducted in patients with acromegaly, paltusotin...

Adverum Biotechnologies Inc

The Biotechnology & Pharmaceuticals company caused great surprise for the stock market, posting a relevant growth in fiscal time-frame closing December 31 2023 with operating deficit of $-26.158 million

Adverum Biotechnologies Inc, a leading biotechnology and pharmaceutical company, has experienced a decrease in its stock by -19.05% in the preceding 30 days. Despite this decline, the year-to-date performance of the company stands at an impressive 105.29%. Currently trading on the NASDAQ, Adverum Biotechnologies Inc's stock is 31.8% above its 52-week average.
During the earnings season from October to December 31, 2023, shareholders did not expect any moderations in the company's top-line performance. However, they were pleasantly surprised by the positive operating deficit of $-26.158 million during the same period. This improvement from the previous quarter's operating deficit of $-33.94 million has increased analysts' confidence in Adverum Biotechnologies Inc.

    News
Inside_Store_pd Management Changes

Teri List Joins Lululemon Board of Directors, Bringing Vast Business Experience to Fuel Global Growth

Published Tue, Mar 19 2024 10:30 AM UTC



Lululemon Athletica Inc (NASDAQ: LULU) has recently announced the appointment of Teri List to its prestigious Board of Directors. Bringing a wealth of business leadership experience and a successful track record as a board member for large international companies, Teri is expected to add significant value to Lululemon as it continues to expand globally. With her in...

industry_industrial_smoke_smog_manufacturing_steel_chimney_stacks_chimneys-655361 Industrial production

Drop in car production led total industrial output down


Production by industry

Capacity utilization by industry

Stock Market
NYSE_By_Kjetil_Ree__[CC-BY-SA-2.5_(http_creativecommons.org_licenses_by-sa_2.5)]

Market Surges as Internet Services and Social Media Stocks Drive Growth

Stock Market Trading


In today's dynamic stock market, Monday, March 18, 2024, the market experienced a surge driven by the Internet Services and Social Media industry, specifically led by Alphabet Inc.
(GOOGL) and Alphabet Inc.
main_engine-installation Product Service News

BOCA RATON, Fla. - Terran Orbitals, a prominent European nano and microsatellite manufacturer, has successfully handed over the Hera Milani satellite to the European Space Agency (ESA) in a formal ceremony held at Tyvak International's premises in Torino, Italy, on March 14th. This significant achievement marks another milestone in the space industry's pursuit of scientific exploration and techn...

Published Tue, Mar 19 2024 10:30 AM UTC

Terran Orbitals Delivers Milani Satellite to European Space Agency for Hera MissionBOCA RATON, Fla. - Terran Orbitals, a prominent European nano and microsatellite manufacturer, has successfully handed over the Hera Milani satellite to the European Space Agency (ESA) in a formal ceremony held at Tyvak International's premises in Torino, Italy, on March 14th. This significant...

Clean_room_By_E.gordienko_(Own_work)__[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Product Service News

Coherent Corp. Breaks Barriers in Optical Networking with Revolutionary Wavemaker and Waveshaper Solutions

Published Tue, Mar 19 2024 10:00 AM UTC

Coherent Introduces Wavemaker and Waveshaper Optical Solutions for Multi-Wavelength TransmissionsPITTSBURGH, March 19, 2024 ?? Coherent Corp. (NYSE: COHR), a global leader in optical networking, announced today the introduction of two new optical test instrumentation products. The Wavemaker and Waveshaper solutions are set to revolutionize multi-wavelength transmissions in t...

8381791238_4cf7083ed0_b[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Product Service News

Confluent Empowers Data Streaming with Tableflow and Simplifies Migration Processes for Businesses.

Published Tue, Mar 19 2024 10:00 AM UTC

Confluent Unveils Tableflow to Unite Analytics and Operations with Data Streaming and Simplify Data Migration ProcessesConfluent, the data streaming pioneer, continues to innovate and expand its offerings with the introduction of Confluent Tableflow and the Confluent Migration Accelerator. These new capabilities aim to make data streaming, connecting, governing, and processi...

turn-on-2932999__340 Producer Price Index

Inflation higher in February 2024

Prices increased on the faster pace again, led by growth in food, materials for manufacturing and crude petroleum prices.

Shopping_in_By_Ramunasjurevicius_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Personal Income and Spending

Consumer spending loses momentum in January 2024

Consumer spending rose by the smallest amount in three months during January 2024, government data showed, in a further sign of erosion in spending momentum.

Bugatti_Veyron_By_Ritchyblack_Stefan_Krause_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Common Auto Sales

U.S. Auto sales fell in January


workers3_pd Product Service News

s. The company's subsidiary, Roy Anderson Corp, has secured a prestigious contract valued at approximately $80.7 million for the construction of a new residence hall at Mississippi State University. This 155,000 square-foot, five-story building will be a welcome addition to the university campus in Starkville, MS.Tutor Perini Corporation's consistent ability to secure such high-profile p...

Published Tue, Mar 19 2024 10:00 AM UTC

Lunda Construction, a subsidiary of Tutor Perini Corporation, has emerged as the apparent low bidder for a significant infrastructure project, further solidifying its position as a leader in the construction industry. The Illinois Department of Transportation has selected Lunda Construction for a bridge replacement and highway improvement project on I-64, near Grayville, Ill...

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Clinical Study

Acromegaly is a rare hormonal disorder caused by the excessive production of growth hormone (GH), which leads to the overgrowth of body tissues. Characterized by abnormal growth in certain body parts, such as the hands, feet, and face, acromegaly also results in various metabolic abnormalities and co-morbidities. One of the primary treatment s for acromegaly is to normalize the levels of insulin...

Published Tue, Mar 19 2024 10:00 AM UTC

Crinetics Pharmaceuticals, a clinical-stage biotechnology company focused on developing innovative therapeutics for rare endocrine diseases and endocrine-related tumors, has announced promising results from two separate studies evaluating the efficacy of their once-daily oral drug, paltusotine. In the Phase 3 PATHFNDR-2 study conducted in patients with acromegaly, paltusotin...

main_engine-installation Product Service News

Joby Aviation Expands Global Reach, Reinforces Industry Leadership with USAF Partnership, Dubai Air Taxi Launch, and FAA Approval

Published Tue, Mar 19 2024 9:30 AM UTC

Joby Aviation Expands USAF Partnership and Secures Dubai Air Taxi Launch, Receives FAA Approval for Propulsion Certification PlanJoby Aviation, an innovative electric air taxi company, continues to make significant advancements in its mission to revolutionize air transportation. The company recently announced multiple milestones, including widening its partnership with the U...

Park-Walking-Recreation-Outdoor-Seoul-People-410256.jpg Products & Services

Blue Hat Interactive Entertainment Technology: Pioneering the Future of AI Financial Services with Strategic Realignment

Published Tue, Mar 19 2024 9:14 AM UTC

Blue Hat Interactive Entertainment Technology: Pioneering the Future of AI Financial ServicesHONG KONG, March 19, 2024 - Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) is making waves in the tech industry as it announces its transition into the realm of AI financial services. With this bold move, the company aims to not only diversify its offerings but als...

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Clinical Study

XORTX Therapeutics Inc.: Pioneering Hope for Progressive Kidney Disease Treatment

Published Tue, Mar 19 2024 9:00 AM UTC

XORTX Therapeutics Inc.: A Promising Future for Progressive Kidney Disease TreatmentXORTX Therapeutics Inc. (XORTX), a leading clinical pharmaceutical company, has achieved significant milestones in 2023 and is poised to make even greater strides in 2024. With a strong focus on developing innovative therapies to combat progressive kidney disease, XORTX is on track to revolut...

Product Service News

JFrog Software Supply Chain Report Exposes Misleading Vulnerability Scores and Highlights Growing Concerns in Software Security

Published Tue, Mar 19 2024 8:15 AM UTC

In an era where technology is progressing at a breakneck speed, the importance of secure software development and delivery cannot be overstated. JFrog Ltd. (NASDAQ: FROG), a leading Liquid Software company known for their Software Supply Chain Platform, has released its annual Software Supply Chain State of the Union report for 2024. This comprehensive report sheds light on ...

Announcement

ObsEva Provides Board of Directors Update and Geneva Court Grants Temporary Moratorium

Published Tue, Mar 19 2024 6:00 AM UTC

In a recent update, ObsEva, a leading biopharmaceutical company focused on women's reproductive health, announced changes to its Board of Directors. These developments, along with a subsequent court ruling, have significant implications for the company's future operations.ObsEva revealed that effective immediately, three new members have joined its Board of Directors. These ...

Announcement

WISeKey International Holding Ltd. Strategically Advances into Web 3.0 and AI Integration, Showcasing Prestigious ProArteyCultura Mayte Spínola Gold Medals at the Iconic Nasdaq Building

Published Tue, Mar 19 2024 6:00 AM UTC

In recent news, WISeKey International Holding Ltd. (WISeKey), a global leader in cybersecurity, digital identity, and Internet of Things (IoT) innovations, has made significant strides towards its strategic goals. The company has announced the appointment of Jonathan LLamas as VP Decentralized Strategy, effective from March 6, 2024, to drive WISeKey's transition into the rea...

Partnership

Revamping Travel in India: EaseMyTrip's Game-Changing Partnerships with Zoomcar and CARS24

Published Tue, Mar 19 2024 4:00 AM UTC

India's travel landscape is undergoing a radical transformation, driven by the strategic partnerships forged by EaseMyTrip, one of the country's leading travel portals. In a recent collaboration with Zoomcar, the pioneer of self-drive car rentals in India, EaseMyTrip is revolutionizing the way in which travelers plan their journeys. Additionally, their partnership with CARS2...

Financing Agreement

Madrigal Pharmaceuticals Leaps Forward with Upsized $600 Million Public Offering and Aims to Transform NASH Treatment Landscape

Published Tue, Mar 19 2024 3:59 AM UTC

Madrigal Pharmaceuticals Announces Upsized $600 Million Public Offering and Record Net Loss
CONSHOHOCKEN, Pa., March 18, 2024 - Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL), a leading biopharmaceutical company specializing in novel therapeutics for nonalcoholic steatohepatitis (NASH), recently disclosed the pricing of its underwritten public offering. The company plans ...

Product Service News

NetApp Inc. Reports Revenue Decrease in Q3 2023, but Achieves Higher Profitability than Competitors

Published Tue, Mar 19 2024 12:04 AM UTC

In the third quarter of 2023, NetApp Inc. (NASDAQ: NTAP) experienced a decline in revenue compared to the previous year, albeit at a faster pace than its competitors. However, the company managed to achieve higher profitability and increase its market share. This article examines the facts and provides an analysis of NetApp Inc.'s performance in the third quarter of 2023.Re...

Zeo Scientifix Inc

Very balanced growth for BPSR during the November to January 31 2024 three months

Zeo Scientifix Inc has shown promising growth in its recent financial results, despite reporting a deficit per share of $-0.17 for the span ending January 31, 2024. This is a significant improvement from the deficit of $-2.287 million in the same period a year ago. The company's revenue also saw a healthy increase of 7.828% to $1.15 million, showing strong growth potential.
One key highlight of the financial report is the notable increase in inventories and supplies, which now stand at $0.3 million. This indicates that the company is investing in its operations and preparing for future growth. Additionally, the decrease in accounts receivable compared to the previous year suggests that the company is effectively managing its cash flow and collections.

Zeo Scientifix Inc 's Price to Book ratio

Zeo Scientifix Inc 's Receivables Turnover Ratio

Adverum Biotechnologies Inc

The Biotechnology & Pharmaceuticals company caused great surprise for the stock market, posting a relevant growth in fiscal time-frame closing December 31 2023 with operating deficit of $-26.158 million

Adverum Biotechnologies Inc, a leading biotechnology and pharmaceutical company, has experienced a decrease in its stock by -19.05% in the preceding 30 days. Despite this decline, the year-to-date performance of the company stands at an impressive 105.29%. Currently trading on the NASDAQ, Adverum Biotechnologies Inc's stock is 31.8% above its 52-week average.
During the earnings season from October to December 31, 2023, shareholders did not expect any moderations in the company's top-line performance. However, they were pleasantly surprised by the positive operating deficit of $-26.158 million during the same period. This improvement from the previous quarter's operating deficit of $-33.94 million has increased analysts' confidence in Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc 's Executive Officers

Adverum Biotechnologies Inc 's Dividend Pay out

Pharmacyte Biotech Inc

The evolving company from the Biotechnology & Pharmaceuticals market the PMCB reported the fiscal third quarter of 2024, numbers

The Biotechnology & Pharmaceuticals industry insiders have begun to analyze the third-quarter earnings of 2024. As of now, the industry insiders have observed an operating loss of $-1.868946 million from a particular company, which has not yet disclosed any revenue for the period from November to January 31, 2024. In order to provide some context for the recent performance, it is worth comparing it to the same period in 2023, when the company reported an operating loss of $-1.552983 million.
One of the notable observations from the third quarter of 2024 earnings season, apart from the absence of revenue, is the significant increase in net deficit. The company recorded a net deficit of $-1.401 million, which is considerably higher than the $-0.764 million reported in the corresponding financial reporting period a year ago.

Pharmacyte Biotech Inc 's Effective Tax Rate

Pharmacyte Biotech Inc 's Free Cash Flow Margin

Avenue Therapeutics Inc

Among many companies, the ATXI reported as well its fourth quarter of 2023 performance

Avenue Therapeutics Inc, a prominent pharmaceutical company, has been making waves in the medical industry with its groundbreaking advancements in the treatment of various neurological disorders. Recently, the company presented its preclinical data on BAER-101 at the American Society for Experimental Neurotherapeutics Annual Meeting, showcasing its full suppression of seizure activity in absence epilepsy. This discovery has the potential to revolutionize anti-seizure drug development and significantly improve the lives of those affected by this condition.
Absence epilepsy is a neurological disorder characterized by intermittent episodes of unconsciousness and staring spells. It predominantly affects children and adolescents, often leading to academic and social challenges. The underlying cause of this condition involves abnormal electrical activity in the brain, resulting in seizures characterized by momentary lapses in consciousness. Prompt and effective treatment is crucial in preventing long-term complications and enhancing the quality of life for individuals with absence epilepsy.

Avenue Therapeutics Inc 's Capital Expenditures Growth

Avenue Therapeutics Inc 's Receivables Turnover Ratio

pills_blue_By_Tom_Varco_(Own_work)_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons Red Cat Holdings Inc

Red Cat Holdings Inc. Skyrockets with 88.24% Revenue Surge in Q3 of 2024

Red Cat Holdings, Inc., a leading drone technology company, has reported record revenue for the company in the Fiscal Third Quarter of 2024. This marks the third consecutive quarter of double-digit sequential growth for Red Cat. The company's revenue rose strongly by 88.24% to $5.85 million from $3.11 million in the same reporting season a year prior. Sequentially, revenue surged by 48.77% from $3.93 million.
The strong revenue growth is a positive sign for Red Cat Holdings, especially considering that the company exceeded its sector peers on the revenue angle. While the rest of the Software & Programming sector expressed a 3.32% top-line elevation during the same period, Red Cat achieved significant growth, indicating its competitive advantage in the market.

Red Cat Holdings Inc 's ROI

Red Cat Holdings Inc 's Revenue Growth




  Events for Tuesday, March 19, 2024  
 
 

The Federal Reserve
Federal Open Market Committee will hold a meeting to discuss interest rates and monetary policy on March 19-20:   
  
 

U.S. Census
U.S. Census will provide a report on New Residential Construction for February 2024   
  
 

U.S. Department of Labor
U.S. Department of Labor issues report on State Job Openings and Labor Turnover for January 2024   
  
 

Abcam Plc
Today Tuesday, March 19, 2024, Abcam Plc reports its full financial results    
  
 

Aileron Therapeutics Inc
Today Tuesday, March 19, 2024, Aileron Therapeutics Inc reports its full financial results    
  
 

Airgain Inc
Today Tuesday, March 19, 2024, Airgain Inc reports its full financial results    
  
 

Akerna Corp
Today Tuesday, March 19, 2024, Akerna Corp reports its full financial results    
  
 

Angel Oak Mortgage Reit Inc
Today Tuesday, March 19, 2024, Angel Oak Mortgage Reit Inc reports its full financial results    
  
 

Apptech Payments Corp
Today Tuesday, March 19, 2024, Apptech Payments Corp reports its full financial results    
  
 

Athenex Inc
Today Tuesday, March 19, 2024, Athenex Inc reports its full financial results    
  
 

Bluejay Diagnostics Inc
Today Tuesday, March 19, 2024, Bluejay Diagnostics Inc reports its full financial results    
  
 

Box Inc
The FY25 Financial Analyst Day event is scheduled for Tuesday, March 19, 2024 at 11:00 a.m. PT. The financial results release date is not specified in the text provided.    
  
 

Camtek Ltd
Today Tuesday, March 19, 2024, Camtek Ltd reports its full financial results    
  
 

Cepton Inc
Today Tuesday, March 19, 2024, Cepton Inc reports its full financial results    
  
 

Chemomab Therapeutics Ltd
Today Tuesday, March 19, 2024, Chemomab Therapeutics Ltd reports its full financial results    
  
 

Citi Trends inc
The financial results will be released before the market opens on Tuesday, March 19, 2024.    
  
 

Cxapp Inc
Today Tuesday, March 19, 2024, Cxapp Inc reports its full financial results    
  
 

Cyclacel Pharmaceuticals Inc
The financial results will be released on Tuesday, March 19, 2024.    
  
 

Defense Technologies International Corp
Today Tuesday, March 19, 2024, Defense Technologies International Corp reports its full financial results    
  
 

Design Therapeutics Inc
The financial results release will be on Tuesday, March 19, 2024.    
  
 

Digital Locations Inc
Today Tuesday, March 19, 2024, Digital Locations Inc reports its full financial results    
  
 

Enzo Biochem Inc
Today Tuesday, March 19, 2024, Enzo Biochem Inc reports its full financial results    
  
 

Eterna Therapeutics Inc
Today Tuesday, March 19, 2024, Eterna Therapeutics Inc reports its full financial results    
  
 

Exagen Inc
Today Tuesday, March 19, 2024, Exagen Inc reports its full financial results    
  
 

Fidelity D and D Bancorp Inc
Today Tuesday, March 19, 2024, Fidelity D and D Bancorp Inc reports its full financial results    
  
 

First Wave Biopharma Inc
Today Tuesday, March 19, 2024, First Wave Biopharma Inc reports its full financial results    
  
 

Gatos Silver Inc
Today Tuesday, March 19, 2024, Gatos Silver Inc reports its full financial results    
  
 

Globus Maritime Limited
Today Tuesday, March 19, 2024, Globus Maritime Limited reports its full financial results    
  
 

Graphite Bio Inc
Today Tuesday, March 19, 2024, Graphite Bio Inc reports its full financial results    
  
 

Growth For Good Acquisition Corp
Today Tuesday, March 19, 2024, Growth For Good Acquisition Corp reports its full financial results    
  
 

Haleon Plc
Today Tuesday, March 19, 2024, Haleon Plc reports its full financial results    
  
 

Keurig Dr Pepper Inc
The financial results release is scheduled for Tuesday, March 19, 2024.    
  
 

Lantern Pharma Inc
Today Tuesday, March 19, 2024, Lantern Pharma Inc reports its full financial results    
  
 

Leo Holdings Corp Ii
Today Tuesday, March 19, 2024, Leo Holdings Corp Ii reports its full financial results    
  
 

Li cycle Holdings Corp
The financial results were released for Li-Cycle Holdings Corp on Tuesday, March 19, 2024.    
  
 

Liquidia Corporation
Today Tuesday, March 19, 2024, Liquidia Corporation reports its full financial results    
  
 

Moonlake Immunotherapeutics
Today Tuesday, March 19, 2024, Moonlake Immunotherapeutics reports its full financial results    
  
 

Nexa Resources S a
Today Tuesday, March 19, 2024, Nexa Resources S a reports its full financial results    
  
 

Rapid Micro Biosystems Inc
The text does not provide any information about the financial results release date for Rapid Micro Biosystems, Inc. It only mentions their participation in the virtual KeyBanc Life Sciences & MedTech Investor Forum on March 19, 2024.    
  
 

Reservoir Media inc
The financial results release is scheduled for March 19, 2024.    
  
 

Rvl Pharmaceuticals Plc
Today Tuesday, March 19, 2024, Rvl Pharmaceuticals Plc reports its full financial results    
  
 

Sanara Medtech Inc
Today Tuesday, March 19, 2024, Sanara Medtech Inc reports its full financial results    
  
 

Sonim Technologies Inc
Today Tuesday, March 19, 2024, Sonim Technologies Inc reports its full financial results    
  
 

Superior Group Of Companies Inc
Today Tuesday, March 19, 2024, Superior Group Of Companies Inc reports its full financial results    
  
 

Taysha Gene Therapies Inc
The financial results will be released on Tuesday, March 19, 2024.    
  
 

Telecom Argentina Sa
Today Tuesday, March 19, 2024, Telecom Argentina Sa reports its full financial results    
  
 

Two
The financial results release will be on Tuesday, March 19, 2024, beginning at 2:00 p.m. ET.    
  
 

Velo3d Inc
Today Tuesday, March 19, 2024, Velo3d Inc reports its full financial results    
  
 

Village Bank and Trust Financial Corp
Today Tuesday, March 19, 2024, Village Bank and Trust Financial Corp reports its full financial results    
  
 

Zumiez Inc
Today Tuesday, March 19, 2024, Zumiez Inc reports its full financial results    
  
 

Comfort Systems Usa inc
Comfort Systems USA Declares Quarterly Dividend; Demonstrating Financial Strength and Commitment to Shareholders
Comfort Systems USA, Inc. (NYSE: FIX), a leading provider of commercial, industrial, and institutional heating, ventilation, air conditioning, and electrical contracting services, has recently announced the declaration of a quarterly dividend of $0.25 per share on its common stock. This move showcases the company's robust financial standing and its commitment to delivering value to its shareholders.
The dividend payout is scheduled for March 19, 2024, and it will be distributed to stockholders of record as of March 8, 2024. This announcement resonates strongly with Comfort Systems USA's stakeholders, reinforcing the company's dedication to its investors.
 

  
 

Compx International inc


In an exciting announcement today, CompX International Inc. revealed its plan to increase its regular quarterly dividend by $0.05 per share. This move comes as a show of confidence from the company's board of directors, highlighting CompX's strong financial performance and commitment to delivering value to its shareholders. The dividend increase positions CompX as an attractive investment opportunity, offering investors a steady income stream and potential for long-term capital appreciation.
CompX International's Dividend Change: A Testament to Success
CompX International Inc., a renowned manufacturer of security products, has consistently displayed robust financial performance and growth over the years. The decision to increase the regular quarterly dividend by $0.05 per share is a reflection of the company's flourishing operations and its ability to generate sustainable cash flows.
 

  
 

Perrigo Company Plc
pays out a quarterly cash dividend of 0.266 per common share to shareholders of record on Perrigo Company Plc as of the shareholder record 2024-03-05  

  
 

Pvh Corp
pays out a quarterly cash dividend of 0.038 per common share to shareholders of record on February 20, 2024  

  
 

Sprott Inc
pays out a quarterly cash dividend per common share to shareholders of record on 2024-03-04  

  
 

Unitedhealth Group Incorporated

The UnitedHealth Group (NYSE: UNH) board of directors recently announced the authorization of a cash dividend of $1.88 per share, setting a payment date of March 19, 2024. This dividend will be distributed to all shareholders of record as of March 11, 2024. This decision reflects the company's commitment to providing value to its shareholders and rewarding their investment in the company.
UnitedHealth Group is a prominent player in the healthcare and well-being sector, with a mission to improve the health and well-being of individuals while simultaneously enhancing the overall efficiency of the healthcare system. The company operates through two distinct and complementary businesses, each contributing to UnitedHealth Group's overall success.
 

  
<< March 2024 >>
Sun. Mon. Tue. Wed. Thu. Fri. Sat.
12
3456789
10111213141516
17181920212223
24252627282930
31

  Events for the week starting March 19, 2024  
 
    
  ECONOMIC INDICATORS      
 

The Federal Reserve
Federal Open Market Committee will hold a meeting to discuss interest rates and monetary policy on March 19-20:   
  
     
 

U.S. Census
U.S. Census will provide a report on New Residential Construction for February 2024   
  
     
 

U.S. Department of Labor
U.S. Department of Labor issues report on State Job Openings and Labor Turnover for January 2024   
  
     
    
    
  FINANCIAL RESULTS      
 Abcam Plc
Today Tuesday, March 19, 2024, Abcam Plc reports its full financial results   
  
     
 Aileron Therapeutics Inc
Today Tuesday, March 19, 2024, Aileron Therapeutics Inc reports its full financial results   
  
     
 Airgain Inc
Today Tuesday, March 19, 2024, Airgain Inc reports its full financial results   
  
     
 Akerna Corp
Today Tuesday, March 19, 2024, Akerna Corp reports its full financial results   
  
     
 Angel Oak Mortgage Reit Inc
Today Tuesday, March 19, 2024, Angel Oak Mortgage Reit Inc reports its full financial results   
  
     
 Apptech Payments Corp
Today Tuesday, March 19, 2024, Apptech Payments Corp reports its full financial results   
  
     
 Athenex Inc
Today Tuesday, March 19, 2024, Athenex Inc reports its full financial results   
  
     
 Bluejay Diagnostics Inc
Today Tuesday, March 19, 2024, Bluejay Diagnostics Inc reports its full financial results   
  
     
 Box Inc
The FY25 Financial Analyst Day event is scheduled for Tuesday, March 19, 2024 at 11:00 a.m. PT. The financial results release date is not specified in the text provided.   
  
     
 Camtek Ltd
Today Tuesday, March 19, 2024, Camtek Ltd reports its full financial results   
  
     
 Cepton Inc
Today Tuesday, March 19, 2024, Cepton Inc reports its full financial results   
  
     
 Chemomab Therapeutics Ltd
Today Tuesday, March 19, 2024, Chemomab Therapeutics Ltd reports its full financial results   
  
     
 Citi Trends inc
The financial results will be released before the market opens on Tuesday, March 19, 2024.   
  
     
 Cxapp Inc
Today Tuesday, March 19, 2024, Cxapp Inc reports its full financial results   
  
     
 Cyclacel Pharmaceuticals Inc
The financial results will be released on Tuesday, March 19, 2024.   
  
     
 Defense Technologies International Corp
Today Tuesday, March 19, 2024, Defense Technologies International Corp reports its full financial results   
  
     
 Design Therapeutics Inc
The financial results release will be on Tuesday, March 19, 2024.   
  
     
 Digital Locations Inc
Today Tuesday, March 19, 2024, Digital Locations Inc reports its full financial results   
  
     
 Enzo Biochem Inc
Today Tuesday, March 19, 2024, Enzo Biochem Inc reports its full financial results   
  
     
 Eterna Therapeutics Inc
Today Tuesday, March 19, 2024, Eterna Therapeutics Inc reports its full financial results   
  
     
 Exagen Inc
Today Tuesday, March 19, 2024, Exagen Inc reports its full financial results   
  
     
 Fidelity D and D Bancorp Inc
Today Tuesday, March 19, 2024, Fidelity D and D Bancorp Inc reports its full financial results   
  
     
 First Wave Biopharma Inc
Today Tuesday, March 19, 2024, First Wave Biopharma Inc reports its full financial results   
  
     
 Gatos Silver Inc
Today Tuesday, March 19, 2024, Gatos Silver Inc reports its full financial results   
  
     
 Globus Maritime Limited
Today Tuesday, March 19, 2024, Globus Maritime Limited reports its full financial results   
  
     
 Graphite Bio Inc
Today Tuesday, March 19, 2024, Graphite Bio Inc reports its full financial results   
  
     
 Growth For Good Acquisition Corp
Today Tuesday, March 19, 2024, Growth For Good Acquisition Corp reports its full financial results   
  
     
 Haleon Plc
Today Tuesday, March 19, 2024, Haleon Plc reports its full financial results   
  
     
 Keurig Dr Pepper Inc
The financial results release is scheduled for Tuesday, March 19, 2024.   
  
     
 Lantern Pharma Inc
Today Tuesday, March 19, 2024, Lantern Pharma Inc reports its full financial results   
  
     
 Leo Holdings Corp Ii
Today Tuesday, March 19, 2024, Leo Holdings Corp Ii reports its full financial results   
  
     
 Li cycle Holdings Corp
The financial results were released for Li-Cycle Holdings Corp on Tuesday, March 19, 2024.   
  
     
 Liquidia Corporation
Today Tuesday, March 19, 2024, Liquidia Corporation reports its full financial results   
  
     
 Moonlake Immunotherapeutics
Today Tuesday, March 19, 2024, Moonlake Immunotherapeutics reports its full financial results   
  
     
 Nexa Resources S a
Today Tuesday, March 19, 2024, Nexa Resources S a reports its full financial results   
  
     
 Rapid Micro Biosystems Inc
The text does not provide any information about the financial results release date for Rapid Micro Biosystems, Inc. It only mentions their participation in the virtual KeyBanc Life Sciences & MedTech Investor Forum on March 19, 2024.   
  
     
 Reservoir Media inc
The financial results release is scheduled for March 19, 2024.   
  
     
 Rvl Pharmaceuticals Plc
Today Tuesday, March 19, 2024, Rvl Pharmaceuticals Plc reports its full financial results   
  
     
 Sanara Medtech Inc
Today Tuesday, March 19, 2024, Sanara Medtech Inc reports its full financial results   
  
     
 Sonim Technologies Inc
Today Tuesday, March 19, 2024, Sonim Technologies Inc reports its full financial results   
  
     
 Superior Group Of Companies Inc
Today Tuesday, March 19, 2024, Superior Group Of Companies Inc reports its full financial results   
  
     
 Taysha Gene Therapies Inc
The financial results will be released on Tuesday, March 19, 2024.   
  
     
 Telecom Argentina Sa
Today Tuesday, March 19, 2024, Telecom Argentina Sa reports its full financial results   
  
     
 Two
The financial results release will be on Tuesday, March 19, 2024, beginning at 2:00 p.m. ET.   
  
     
 Velo3d Inc
Today Tuesday, March 19, 2024, Velo3d Inc reports its full financial results   
  
     
 Village Bank and Trust Financial Corp
Today Tuesday, March 19, 2024, Village Bank and Trust Financial Corp reports its full financial results   
  
     
 Zumiez Inc
Today Tuesday, March 19, 2024, Zumiez Inc reports its full financial results   
  
     
    
    
  DIVIDEND PAYOUT      
 Comfort Systems Usa inc
Comfort Systems USA Declares Quarterly Dividend; Demonstrating Financial Strength and Commitment to Shareholders
Comfort Systems USA, Inc. (NYSE: FIX), a leading provider of commercial, industrial, and institutional heating, ventilation, air conditioning, and electrical contracting services, has recently announced the declaration of a quarterly dividend of $0.25 per share on its common stock. This move showcases the company's robust financial standing and its commitment to delivering value to its shareholders.
The dividend payout is scheduled for March 19, 2024, and it will be distributed to stockholders of record as of March 8, 2024. This announcement resonates strongly with Comfort Systems USA's stakeholders, reinforcing the company's dedication to its investors.
  
     
 Compx International inc


In an exciting announcement today, CompX International Inc. revealed its plan to increase its regular quarterly dividend by $0.05 per share. This move comes as a show of confidence from the company's board of directors, highlighting CompX's strong financial performance and commitment to delivering value to its shareholders. The dividend increase positions CompX as an attractive investment opportunity, offering investors a steady income stream and potential for long-term capital appreciation.
CompX International's Dividend Change: A Testament to Success
CompX International Inc., a renowned manufacturer of security products, has consistently displayed robust financial performance and growth over the years. The decision to increase the regular quarterly dividend by $0.05 per share is a reflection of the company's flourishing operations and its ability to generate sustainable cash flows.
  
     
 Perrigo Company Plc
pays out a quarterly cash dividend of 0.266 per common share to shareholders of record on Perrigo Company Plc as of the shareholder record 2024-03-05
  
     
 Pvh Corp
pays out a quarterly cash dividend of 0.038 per common share to shareholders of record on February 20, 2024
  
     
 Sprott Inc
pays out a quarterly cash dividend per common share to shareholders of record on 2024-03-04
  
     
 Unitedhealth Group Incorporated

The UnitedHealth Group (NYSE: UNH) board of directors recently announced the authorization of a cash dividend of $1.88 per share, setting a payment date of March 19, 2024. This dividend will be distributed to all shareholders of record as of March 11, 2024. This decision reflects the company's commitment to providing value to its shareholders and rewarding their investment in the company.
UnitedHealth Group is a prominent player in the healthcare and well-being sector, with a mission to improve the health and well-being of individuals while simultaneously enhancing the overall efficiency of the healthcare system. The company operates through two distinct and complementary businesses, each contributing to UnitedHealth Group's overall success.
  
     
    
<< March 2024 >>
Sun. Mon. Tue. Wed. Thu. Fri. Sat.
12
3456789
10111213141516
17181920212223
24252627282930
31




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com